TIGAR and intestinal cancer: Considering the hallmark of reprogrammed metabolic pathways in cancer cells, it is not surprised to find dysregulated TIGAR expression in various cancer types, including lung cancer, intestinal cancer, liver cancer, and glioma 22, 25-27.